COMPASS Pathways (CMPS)
NASDAQ: CMPS
· Real-Time Price · USD
2.77
0.11 (4.14%)
At close: Jun 27, 2025, 3:59 PM
2.75
-0.90%
After-hours: Jun 27, 2025, 05:36 PM EDT
4.14% (1D)
| Bid | 2.74 |
| Market Cap | 257.65M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -137.8M |
| EPS (ttm) | -1.99 |
| PE Ratio (ttm) | -1.39 |
| Forward PE | -1.95 |
| Analyst | Buy |
| Ask | 2.83 |
| Volume | 3,104,148 |
| Avg. Volume (20D) | 2,128,919 |
| Open | 2.67 |
| Previous Close | 2.66 |
| Day's Range | 2.61 - 2.83 |
| 52-Week Range | 2.25 - 8.54 |
| Beta | 2.25 |
About CMPS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CMPS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CMPS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 days ago
+7.66%
Shares of psychedelic companies are trading higher...
Unlock content with
Pro Subscription
4 days ago
-49.24%
COMPASS Pathways shares are trading lower. The company announced it reached its primary endpoint in the ongoing Phase 3 COMP005 trial.
3 days ago · proactiveinvestors.com
Compass Pathways' late-stage psilocybin trial targeting treatment-resistant depression meets primary endpointCompass Pathways (NASDAQ:CMPS) has reported positive results from its Phase 3 trial of its synthetic formulation of psilocybin, COMP360, in patients with treatment-resistant depression (TRD), with the...
3 weeks ago · https://www.proactiveinvestors.com
Meta to roll out AI-powered ad creation by late 2025, says WSJMeta Platforms Inc (NASDAQ:META, ETR:FB2A, SWX:FB) is planning to let brands fully create and target ads using its artificial intelligence tools by the end of 2025, according to a report in the Wall S...
